Condensed Consolidated Statements of Equity - USD ($) $ in Thousands		Total	Cross currency swap	Interest rate swap	Total	Total Cross currency swap	Total Interest rate swap	Common Stock	Additional Paid-in Capital	Treasury Stock	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Accumulated Other Comprehensive Income (Loss) Cross currency swap	Accumulated Other Comprehensive Income (Loss) Interest rate swap	Noncontrolling Interest
Balance (in shares) at Dec. 31, 2024								60,501,000
Balance at the start of the period at Dec. 31, 2024		$ 2,550,932			$ 2,425,129			$ 61	$ 1,635,245	$ (17,964)	$ 814,518	$ (6,731)			$ 125,803
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation		4,911			4,911				4,911
Exercise of stock-based awards by employees and directors (in shares)	[1]							162,000
Exercise of stock-based awards by employees and directors	[1]	754			754				754
Cash paid to noncontrolling interest		(2,767)													(2,767)
Cash dividend declared		(7,273)			(7,273)						(7,273)
Net income		41,317			40,362						40,362				955
Other comprehensive income (loss), net of related taxes:
Currency translation adjustments		2,761			2,183							2,183			578
Change in unrealized gains or losses in respect of the Company's share in derivatives instruments of an unconsolidated investment that qualifies as a cash flow hedge		(896)			(896)							(896)
Change in unrealized gains or losses in respect of a cross-currency swap / interest rate swap derivative instrument that qualifies as a cash flow hedge			$ (3,466)	$ (512)		$ (3,466)	$ (512)						$ (3,466)	$ (512)
Other		12			12							12
Balance (in shares) at Mar. 31, 2025								60,663,000
Balance at the end of the period at Mar. 31, 2025		2,585,773			2,461,204			$ 61	1,640,910	(17,964)	847,607	(9,410)			124,569
Balance (in shares) at Dec. 31, 2025								60,845,000
Balance at the start of the period at Dec. 31, 2025		2,680,874			2,543,943			$ 61	1,654,635	(17,964)	909,343	(2,132)			136,931
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation		4,724			4,724				4,724
Exercise of stock-based awards by employees and directors (in shares)	[1]							232,000
Gain from induced conversion		6,684			6,684				6,684
Common stock issuance for convertible note repayment (in shares)								600,000
Common stock issuance for convertible note repayment		$ 1			1			$ 1
Purchase of treasury stock (in shares)		(224,593)						(225,000)
Purchase of treasury stock		$ (24,395)			(24,395)					(24,395)
Cash paid to noncontrolling interest		(2,077)													(2,077)
Cash dividend declared		(7,506)			(7,506)						(7,506)
Increase in noncontrolling interest related to tax monetization transactions		2,508													2,508
Net income		44,637			44,068						44,068				569
Other comprehensive income (loss), net of related taxes:
Currency translation adjustments		1,098			1,508							1,508			(410)
Change in unrealized gains or losses in respect of the Company's share in derivatives instruments of an unconsolidated investment that qualifies as a cash flow hedge		64			64							64
Change in unrealized gains or losses in respect of a cross-currency swap / interest rate swap derivative instrument that qualifies as a cash flow hedge			$ 369	$ 1,478		$ 369	$ 1,478						$ 369	$ 1,478
Other		1			1							1
Balance (in shares) at Mar. 31, 2026								61,452,000
Balance at the end of the period at Mar. 31, 2026		$ 2,708,460			$ 2,570,939			$ 62	$ 1,666,043	$ (42,359)	$ 945,905	$ 1,288			$ 137,521

[1] Resulted in an amount lower than $1,000.